In this video from MDLinx, Dr. Martine Piccart, PhD & Head of the Medicine Department at the Jules Bordet Institute and Co-Founder of the Breast International Group, talks about a breakthrough study that focuses on how using MammaPrint genetic testing can reduce the use of chemotherapy over-treatment in breast cancer patients.
Breast Cancer News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?